Angios is a biotechnology company, specializing in vascular research to improve patients' lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Exlgasse 20a, Innsbruck,tyrol 6020,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.angios-bio.com
- HQ
- Innsbruck, Tyrol
Angios Flexco Questions
Angios Flexco's website is http://www.angios-bio.com
Angios Flexco's LinkedIn profile is https://at.linkedin.com/company/angios-gmbh
Angios Flexco has
12 employees.
View email and phone details for 12
employees at Angios Flexco.
Angios Flexco's industry is
Biotechnology Research
Angios Flexco's top competitors are
Kincon Biolabs,
Syndena,
Qubicon,
Biotech Austria,
Sola Diagnostics Gmbh,
Viratherapeutics Gmbh,
Simvantage,
Enzyan Biocatalysis Gmbh,
Biocrates Life Sciences Ag,
Innovacell Gmbh.
Angios Flexco's categories are Biotechnology Research
Angios Flexco's founding year is 2021
